Hansa Biopharma AB (publ) (0RC7)
Market Closed
16 Oct, 03:30 PM
kr
36. 88
+1.81
+5.1611%
kr
2.08B Market Cap
- P/E Ratio
- Div Yield
2,352 Volume
0 Eps
kr 35.07
Previous Close Want to track 0RC7 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hansa Biopharma AB (publ) (0RC7) Statistics
Valuation metrics
Market Cap 2.08B
Enterprise value 2.63B
Trailing P/E (ttm) -5.35
Forward P/E -
PEG ratio 0.46
Price/Sales (ttm) 18.67
Price/Book (mrq) -26.51
Enterprise Value/Revenue 19.62
Enterprise Value/EBITDA -3.35
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 876
Average volume (90 days) 6.45K
Price summary
52-Week low 23.57
52-Week high 48
Beta -
50-Day moving average 38.72
200-Day moving average 34.19
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 816:775
Last split Date 16 Mar 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.2%
Operating margin -5.88%
Operational effectiveness
Return on assets -0.82%
Return on equity -3.82%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.55
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -15.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.93
Total debt (mrq) -
Total Debt/Equity (mrq) -5.12
Current ratio (mrq) 2.66%
Book value per share (mrq) -3.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
